Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for weight loss prevention in children with cancer
NCT01132547Phase 3Terminated
- Sponsor
- University of South Florida
- Start
- Jun 2010
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyproheptadine, sponsored by University of South Florida. Started Jun 2010; status: terminated.
02
Drugs
cyproheptadine
Beyond the preview
Go deeper on NCT01132547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01132547.